سعر فاسلو Vaslow‏ 10/160/12.5 مجم 10 اقراص 2026

Fixed-dose triple antihypertensive (amlodipine/valsartan/hydrochlorothiazide 10/160/12.5 mg) film-coated tablets by Pharco B, Egypt.

• Contraindicated in anuria, sulfonamide hypersensitivity and with aliskiren in patients with diabetes.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypotension in volume-depleted patients, electrolyte and metabolic disturbances, renal impairment, acute myopia/angle-closure glaucoma and SLE exacerbation (hydrochlorothiazide).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• LithiumIncreased lithium levels and toxicity; monitor lithium levels.DailyMed (U.S. National Library of Medicine)
• NSAIDsMay reduce antihypertensive effect and worsen renal function.DailyMed (U.S. National Library of Medicine)

• Boxed warning: drugs acting on the renin-angiotensin system can cause fetal injury and death; discontinue as soon as pregnancy is detected.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Amlodipine: Inhibits transmembrane calcium influx into vascular smooth muscle and cardiac muscle; peripheral arterial vasodilator.
• Valsartan: Blocks vasoconstrictor and aldosterone-secreting effects of angiotensin II at the AT1 receptor.
• Hydrochlorothiazide: Promotes renal excretion of sodium and chloride, reducing intravascular volume.